The company AsurBrok and the Biomedical Research Institute of Lleida (IRBLleida) sign a new collaboration agreement to promote research in Lleida.

AsurBrok is an insurance broker with more than 31 years of history and who works every day to give the best of themselves and get their customers to renew their confidence year after year.

The company signs this collaboration agreement for the fourth consecutive year. These collaborations allow research on very relevant diseases such as cancer, stroke, multiple sclerosis, diabetes, the nervous system, the cardiovascular system, among others, and help provide better services to the population.

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream